Benigno C Valdez Selected Research

Sorafenib (BAY 43-9006)

11/2014

Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benigno C Valdez Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 10/2012
11	Lymphoma (Lymphomas) 10/2022 - 05/2012
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2008
7	Myeloid Leukemia (Leukemia, Myelocytic) 11/2018 - 11/2008
6	Leukemia 03/2024 - 06/2011
3	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 07/2010
3	Mandibulofacial Dysostosis (Treacher Collins Syndrome) 10/2005 - 07/2004
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 06/2011
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2018
2	Multiple Myeloma 01/2020 - 08/2013
2	Mucositis 06/2017 - 01/2016
2	Dermatitis 06/2017 - 01/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 06/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2016 - 06/2011
1	Chronic Pain 03/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2012

Drug/Important Bio-Agent (IBA)

19	Busulfan (Busulfex)FDA Link 10/2022 - 11/2008
11	Gemcitabine FDA Link 10/2022 - 05/2012
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 07/2010
8	Alkylating AgentsIBA 01/2023 - 05/2012
8	NucleosidesIBA 01/2023 - 05/2012
8	Melphalan (Alkeran)FDA LinkGeneric 10/2022 - 10/2012
8	Clofarabine (Clolar)FDA Link 01/2022 - 06/2011
7	fludarabineIBA 01/2022 - 06/2011
5	Vorinostat FDA Link 01/2022 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2016
4	PanobinostatIBA 01/2022 - 11/2016
4	Decitabine FDA Link 01/2022 - 03/2010
3	Drug CombinationsIBA 03/2024 - 11/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022 - 11/2017
3	Histone Deacetylase InhibitorsIBA 10/2022 - 07/2014
3	venetoclaxIBA 01/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 11/2018
2	ChromatinIBA 10/2022 - 01/2018
2	olaparibIBA 01/2022 - 11/2017
2	perfosfamideIBA 11/2018 - 01/2017
2	romidepsin (FK228)FDA Link 01/2018 - 09/2016
2	Rituximab (Mabthera)FDA Link 01/2016 - 11/2015
2	AntigensIBA 01/2016 - 06/2011
2	MethyltransferasesIBA 01/2016 - 10/2012
2	nasIBA 01/2016 - 05/2012
1	Ketoprofen (Orudis)FDA LinkGeneric 03/2024
1	CaspasesIBA 10/2022
1	bisantreneIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	Naltrexone (ReVia)FDA LinkGeneric 03/2020
1	CytokinesIBA 03/2020
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	niraparibIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	4-nitrophenethyl bromide (NPB)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 06/2017
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2017
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 01/2017
1	Chlorambucil (Leukeran)FDA Link 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Everolimus FDA Link 01/2017
1	Bortezomib (Velcade)FDA Link 11/2016
1	Complement System Proteins (Complement)IBA 10/2016
1	Messenger RNA (mRNA)IBA 09/2016
1	multidrug resistance-associated protein 1IBA 09/2016
1	Azacitidine (5 Azacytidine)FDA Link 01/2016
1	Annexin A5IBA 01/2016
1	Cladribine FDA LinkGeneric 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 11/2014
1	fms-Like Tyrosine Kinase 3IBA 11/2014
1	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2012
1	Histones (Histone)IBA 10/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2011
1	thymoglobulin FDA Link 06/2011
1	Tyrosine Kinase InhibitorsIBA 06/2011
1	A-Form DNA (A-DNA)IBA 03/2010
1	PhosphoproteinsIBA 10/2005
1	RNA Precursors (Precursor, mRNA)IBA 07/2005
1	Ribosomal DNA (rDNA)IBA 07/2004
1	transcription factor UBFIBA 07/2004

Therapy/Procedure

11	Hematopoietic Stem Cell Transplantation 02/2024 - 11/2008
6	Stem Cell Transplantation 01/2018 - 06/2011
5	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
3	Therapeutics 01/2018 - 07/2010
1	Aftercare (After-Treatment) 10/2016